Mod­er­na's Stéphane Ban­cel plans to dou­ble down on vac­cine pro­duc­tion, new vari­ants as mR­NA rules in pan­dem­ic fight

Stéphane Ban­cel thought he’d be sleep­ing more by now.

The 48-year-old Mod­er­na CEO fig­ured that by 2021 he’d have his vac­cine through the clin­ic, au­tho­rized, and in mass pro­duc­tion — that the hard part would be over. In­stead, he’s still work­ing Sat­ur­days and Sun­days, talk­ing with his lab and man­u­fac­tur­ing teams and field­ing calls with two to three world lead­ers a day to an­swer their con­cerns about sup­ply and emerg­ing new vari­ants.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.